Literature DB >> 28840524

Prevalence of Anal Human Papillomavirus Infection in Hungarian Men Who Have Sex with Men.

Eszter Szabó1,2, Csaba Kósa3, Edit Babarczi4, Mihály Sulyok5,6, Eszter Ujhelyi7, Dénes Bánhegyi3, István Vályi-Nagy8.   

Abstract

Anal cancer is one of the leading causes of death in non-AIDS defining cancers. Most of these cancers are associated with high risk HPV infection. So far, the prevalence and the significance of anal HPV infection have not been studied in the Hungarian MSM population. The main objective of our study was to determine the prevalence and associated risk factors of HPV-infection in the Hungarian MSM community, particularly in HIV-infected MSM. Out of 109 examinations 92 samples (80 HIV-infected and 12 HIV-negative MSM) were evaluated for both cytological abnormalities and HPV genotyping PCR. Using a questionnaire all enrolled individuals were interviewed about their sexual behavior, socioeconomic factors, drug use and other known or suspected risk factors. In the HIV-infected cohort 97.5% of the examined individuals were positive for any HPV type. In this group we detected high risk (HR) HPV in 88.8%, low risk (LR) HPV in 75.0% and probably high risk (PHR) HPV in 47.5% and multiple HPV infection was absolutely common (82.5%). In the HIV-negative MSM group the incidence of HPV-infection was 58.3%. The respective rate of HR-HPV, LR-HPV and PHR-HPV genotypes were 33.3%, 58.4%, and 16.7%. In the HIV-negative group both HPV infection frequency and the prevalence of the pertinent genotypes were much lower. The Hungarian MSM population is severely infected with HPV and HR-HPV. High-risk sexual behaviors are strong predictors for acquiring HR-HPV co-infections. Our results underline the necessity of anal cancer screening and the introduction of the vaccination program in the high-risk population.

Entities:  

Keywords:  Anal cancer screening; HIV-infected MSM; HPV; HPV genotype; MSM; Risk factor

Mesh:

Year:  2017        PMID: 28840524     DOI: 10.1007/s12253-017-0292-5

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  32 in total

1.  Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

Authors:  Frank J Palella; Rose K Baker; Anne C Moorman; Joan S Chmiel; Kathleen C Wood; John T Brooks; Scott D Holmberg
Journal:  J Acquir Immune Defic Syndr       Date:  2006-09       Impact factor: 3.731

2.  Anal cytology as a screening tool for anal squamous intraepithelial lesions.

Authors:  J M Palefsky; E A Holly; C J Hogeboom; J M Berry; N Jay; T M Darragh
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-04-15

3.  Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men.

Authors:  Timothy Wilkin; Jeannette Y Lee; Shelly Y Lensing; Elizabeth A Stier; Stephen E Goldstone; J Michael Berry; Naomi Jay; David Aboulafia; David L Cohn; Mark H Einstein; Alfred Saah; Ronald T Mitsuyasu; Joel M Palefsky
Journal:  J Infect Dis       Date:  2010-10-15       Impact factor: 5.226

4.  Anal cancer and screening guidelines for human papillomavirus in men.

Authors:  Richard A Ortoski; Christine S Kell
Journal:  J Am Osteopath Assoc       Date:  2011-03

5.  The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men.

Authors:  S J Goldie; K M Kuntz; M C Weinstein; K A Freedberg; M L Welton; J M Palefsky
Journal:  JAMA       Date:  1999-05-19       Impact factor: 56.272

6.  The global health burden of infection-associated cancers in the year 2002.

Authors:  Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2006-06-15       Impact factor: 7.396

7.  Prevalence and risk factors associated with anal intraepithelial neoplasia among HIV-positive men in Brazil.

Authors:  Victor Hugo Melo; Mark Drew Crosland Guimaraes; Gustavo Machado Rocha; Angela Cristina Labanca Araujo; Ricardo Andrade Carmo; Beatriz Grinsztejn; José Henrique Pilotto; Joel Michael Palefsky
Journal:  J Low Genit Tract Dis       Date:  2014-04       Impact factor: 1.925

8.  Understanding the burden of human papillomavirus-associated anal cancers in the US.

Authors:  Djenaba A Joseph; Jacqueline W Miller; Xiaocheng Wu; Vivien W Chen; Cyllene R Morris; Marc T Goodman; Jose M Villalon-Gomez; Melanie A Williams; Rosemary D Cress
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

9.  Cancer in a population-based cohort of men and women in registered homosexual partnerships.

Authors:  Morten Frisch; Else Smith; Andrew Grulich; Christoffer Johansen
Journal:  Am J Epidemiol       Date:  2003-06-01       Impact factor: 4.897

10.  Self-collected versus clinician-collected anal cytology specimens to diagnose anal intraepithelial neoplasia in HIV-positive men.

Authors:  Ross D Cranston; Teresa M Darragh; Elizabeth A Holly; Naomi Jay; J Michael Berry; Maria Da Costa; Jimmy T Efird; Joel M Palefsky
Journal:  J Acquir Immune Defic Syndr       Date:  2004-08-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.